1 Reynaud Q, "Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis" 13 : 595-608, 2014
2 Manautou L, "Myopericarditis with predominantly right ventricular involvement with normal B-type natriuretic peptide and cardiac tamponade as the initial manifestation of systemic lupus erythematosus" 23 : 935-938, 2014
3 Kassaian SE, "Myocardial infarction secondary to premature coronary artery disease as the initial major manifestation of systemic lupus erythematosus" 19 : 152-154, 2008
4 Korkmaz C, "Myocardial infarction in young patients (< or =35 years of age) with systemic lupus erythematosus: a case report and clinical analysis of the literature" 16 : 289-297, 2007
5 Jawaid A, "Cardiac tamponade as initial presentation in systemic lupus erythematosus" 24 (24): S138-S140, 2014
6 Koniari I, "Antiphospholipid syndrome;its implication in cardiovascular diseases: a review" 5 : 101-, 2010
7 Manzi S, "Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study" 145 : 408-415, 1997
8 González-Pacheco H, "Acute left main coronary artery thrombosis as the first manifestation of systemic lupus erythematosus and catastrophic antiphospholipid syndrome" 32 : 197.e3-197.e5, 2014
9 Klein AJ, "Acute left main coronary arterial thrombosis - a case series" 20 : E243-E246, 2008
10 Chou CH, "A nationwide population-based retrospective cohort study:increased risk of acute myocardial infarction in systemic lupus erythematous patients" 174 : 751-753, 2014
1 Reynaud Q, "Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis" 13 : 595-608, 2014
2 Manautou L, "Myopericarditis with predominantly right ventricular involvement with normal B-type natriuretic peptide and cardiac tamponade as the initial manifestation of systemic lupus erythematosus" 23 : 935-938, 2014
3 Kassaian SE, "Myocardial infarction secondary to premature coronary artery disease as the initial major manifestation of systemic lupus erythematosus" 19 : 152-154, 2008
4 Korkmaz C, "Myocardial infarction in young patients (< or =35 years of age) with systemic lupus erythematosus: a case report and clinical analysis of the literature" 16 : 289-297, 2007
5 Jawaid A, "Cardiac tamponade as initial presentation in systemic lupus erythematosus" 24 (24): S138-S140, 2014
6 Koniari I, "Antiphospholipid syndrome;its implication in cardiovascular diseases: a review" 5 : 101-, 2010
7 Manzi S, "Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study" 145 : 408-415, 1997
8 González-Pacheco H, "Acute left main coronary artery thrombosis as the first manifestation of systemic lupus erythematosus and catastrophic antiphospholipid syndrome" 32 : 197.e3-197.e5, 2014
9 Klein AJ, "Acute left main coronary arterial thrombosis - a case series" 20 : E243-E246, 2008
10 Chou CH, "A nationwide population-based retrospective cohort study:increased risk of acute myocardial infarction in systemic lupus erythematous patients" 174 : 751-753, 2014